Cosmos Health Inc.
COSM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.02 | -0.01 | 0.03 | -0.03 |
| FCF Yield | -11.72% | -11.00% | -1.92% | -37.12% |
| EV / EBITDA | -12.58 | -14.08 | -72.61 | -2.90 |
| Quality | ||||
| ROIC | -3.96% | -6.04% | -2.04% | -23.40% |
| Gross Margin | 15.21% | 7.89% | 14.95% | 7.06% |
| Cash Conversion Ratio | 0.74 | 0.43 | 0.23 | 0.40 |
| Growth | ||||
| Revenue 3-Year CAGR | 6.44% | 4.14% | 2.57% | 2.63% |
| Free Cash Flow Growth | -199.88% | -563.85% | 95.79% | -1,030.61% |
| Safety | ||||
| Net Debt / EBITDA | -4.69 | -7.80 | -38.98 | -1.37 |
| Interest Coverage | -2.72 | -4.79 | -4.45 | -28.04 |
| Efficiency | ||||
| Inventory Turnover | 2.55 | 2.66 | 2.46 | 3.04 |
| Cash Conversion Cycle | 47.50 | 59.75 | 58.76 | 54.17 |